TARRYTOWN, N.Y., Oct. 18, 2019 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management
presentations as follows:
- Credit Suisse 28th Annual Healthcare Conference at
10:00 a.m. EST (8:00 a.m. MST) on Tuesday,
November 12, 2019
- Jefferies 2019 London Healthcare Conference at 9:00 a.m. EST (2:00 p.m.
GMT) on Wednesday, November 20,
2019
The sessions may be accessed from the "Investors & Media"
page of Regeneron's website at
http://investor.regeneron.com/events-and-presentations. Replays of
the webcasts will be archived on the Company's website.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a
leading biotechnology company that invents life-transforming
medicines for people with serious diseases. Founded and led for 30
years by physician-scientists, our unique ability to repeatedly and
consistently translate science into medicine has led to seven
FDA-approved treatments and numerous product candidates in
development, all of which were homegrown in our laboratories. Our
medicines and pipeline are designed to help patients with eye
diseases, allergic and inflammatory diseases, cancer,
cardiovascular and metabolic diseases, infectious diseases, pain
and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through its proprietary
VelociSuite® technologies, such as
VelocImmune® which produces optimized fully-human
antibodies, and ambitious research initiatives such as the
Regeneron Genetics Center, which is conducting one of the largest
genetics sequencing efforts in the world.
For additional information about the company, please visit
www.regeneron.com or follow @Regeneron on Twitter.
Contact Information:
Investor Relations
Justin Holko
914.847.7786
justin.holko@regeneron.com
Corporate Communications
Hala Mirza
914.847.3422
hala.mirza@regeneron.com
View original
content:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300941158.html
SOURCE Regeneron Pharmaceuticals, Inc.